UNSPSC 51284610: Ertapenem sodium

This classification denotes a beta-lactam antibiotic with the molecular formula C22H23N3O7S.H+.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2T90KE67L0, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-(((3-carboxyphenyl)amino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, disodium salt, (4r-(3(3s*,5s*),4alpha,5beta,6beta(r*)))- but more generally known as ertapenem sodium, which bears US NIH Compound Identifier 150611.

UNSPSC 51284610 Ertapenem sodium is a Commodity code nominally designating a specific antibiotic pharmaceutical, but recent state and local opportunities do not align with procurement of this agent. Instead, the code appears in solicitations for broader medical and pharmaceutical supply categories — including naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, emergency medical supplies for fire and rescue operations, and direct-to-manufacturer prescription fulfillment programs. State and local governments are using this code tag to procure emergency response medications, pharmacy benefit management services, and first-aid consumables through competitive bidding processes and cooperative purchasing arrangements. Issuing bodies include county health departments, state health and human services commissions, municipal fire departments, and state-administered multistate cooperative purchasing alliances. The work being solicited spans annual supply agreements with fixed terms and renewal options, volume-based purchasing through established pharmaceutical wholesalers, and exploratory market-research phases ahead of formal competitive solicitations.

Recent activity appears across Florida, Texas, Minnesota, and Oregon through geographically dispersed issuers. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP due March 26, 2026 for generic pharmaceuticals and OTC products across participating state and local facilities, requiring compliance with cGMP, DSCSA, and specific pricing formats through authorized wholesalers including AmerisourceBergen, Cardinal Health, and Morris & Dickson. The City of Tampa issued an IFB (Bid 26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies — respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, and consumables — for the Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a 5 percent SLBE bid discount. Seminole County, Florida solicited naloxone and drug deactivation systems (IFB 60459723LAS, due July 26, 2023) for quarterly delivery to the county's community health building. The Texas Health and Human Services Commission issued an RFI (HHS0017013, posted April 3, 2026) seeking vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. The code shows mixed relevance to the nominal ertapenem product; vendors should evaluate whether they supply the broader medical and pharmaceutical categories actually being bought under this code.